Rezolute (RZLT) Accounts Payables (2011 - 2026)
Rezolute's (RZLT) quarterly Accounts Payables came in at $3.2 million in Q1 2026, down 50.86% year-on-year from $6.5 million in Q1 2025, and down 15.54% quarter-over-quarter from $3.8 million in Q4 2025.
Rezolute (RZLT) Accounts Payables (2011 - 2026) Analysis & Trends
Rezolute has disclosed Accounts Payables across 16 years of filings, most recently posting $3.2 million for Q1 2026.
- Accounts Payables for Q1 2026 came in at $3.2 million, down 50.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.2 million (down 50.86% YoY), and the FY2025 annual result was $5.8 million, up 18.53% from the prior year.
- Accounts Payables came in at $3.2 million for Q1 2026 at Rezolute, down from $3.8 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $6.5 million in Q1 2025 to a low of $1.1 million in Q3 2022.
- The 5-year median for Accounts Payables is $3.2 million (2026), against an average of $3.2 million.
- Across the five-year window, Accounts Payables jumped 188.78% in 2023 and tumbled 50.86% in 2026, its largest moves.
- Rezolute's Accounts Payables stood at $2.8 million in 2022, then rose by 26.47% to $3.6 million in 2023, then dropped by 12.36% to $3.1 million in 2024, then increased by 20.13% to $3.8 million in 2025, then slipped by 15.54% to $3.2 million in 2026.
- The last three Accounts Payables figures came in at $3.2 million (Q1 2026), $3.8 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.64 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | 3.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.20 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 5.81 Mn |
| Mar 31, 2025 | 6.50 Mn |
| Dec 31, 2024 | 3.15 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 4.90 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | 3.59 Mn |
| Sep 30, 2023 | 2.43 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 2.84 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.13 Mn |
| Mar 31, 2022 | 1.56 Mn |
| Dec 31, 2021 | 4.35 Mn |
| Sep 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 1.04 Mn |